Loading stock data…
COMP
$7.39-0.18 (-2.38%)
Market ClosedLast close May 1
Compass, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Compass, Inc. in the Real Estate sector is trading at $7.39. The stock is currently 47% below its 52-week high of $13.96, remaining 19.5% below its 200-day moving average. Technical signals show neutral RSI of 55 and bullish MACD crossover, explaining why COMP maintains its current current market pressure. The Whystock Score of 50/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 55) — price action in range
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$7.39
Potential Upside
5%
Whystock Fair Value$7.76
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus12 analysts
Buy
Mean target$12.83+73.7%
Range$9.00 – $17.00
Fundamentals
Compass, Inc. provides an end-to-end technology platform for residential real estate in the United States. The company offers the Compass Platform, a technology platform that provides an integrated suite of cloud-based software for customer relations...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$5.90B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
2.63
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-6.84%
Volume
Today's trading volume
10.18M
Recent News
HubSpot (HUBS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
HubSpot (HUBS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Compass, Inc. (COMP) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
Compass (COMP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Compass Therapeutics’s stock crashes after OS miss in BTC trial
Compass Therapeutics will still submit tovecimig for approval despite the OS miss.
Q4 Rundown: Compass (NYSE:COMP) Vs Other Consumer Discretionary - Real Estate Services Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Compass (NYSE:COMP) and the best and worst performers in the consumer discretionary - real estate services industry.
Compass Therapeutics Touts “Stunning” PFS Win in COMPANION-002 as Crossover Muddy OS Data
Compass Therapeutics (NASDAQ:CMPX) executives highlighted what CEO and Vice Chair Dr. Thomas Schuetz called “absolutely stunning” progression-free survival results from the company’s phase II/III COMPANION-002 trial in second-line advanced biliary tract cancer, while also detailing how patient cross